Home | Welcome to Contract Pharma   
Last Updated Friday, October 24 2014
Print

Breaking News

June 2, 2014
To develop and commercialize ODM-201 to treat prostate cancer  Read More »
June 2, 2014
Expands commercial manufacturing capabilities for specialty injectables  Read More »
May 30, 2014
Shih oversee all medical, clinical and research functions  Read More »
May 30, 2014
To develop DNA and RNA biomarker assays in common cancers  Read More »
May 29, 2014
Janssen to take on prostate cancer candidates  Read More »
May 29, 2014
Revenues up 8% in 2013  Read More »
May 29, 2014
To assess the dosing and performance of a subunit antigen vaccine candidate  Read More »
May 29, 2014
Aims to enhance early phase clinical research in South Korea  Read More »
May 29, 2014
To develop solid dosage manufacturing, packing facility at Manati site  Read More »
May 28, 2014
To pursue OTC approval  Read More »
May 28, 2014
Adds HPAPI processing capabilities at Shanghai lab  Read More »
May 28, 2014
Pretorius to lead clinical research methodologies  Read More »
May 28, 2014
Establishes Anti-Infectives Platform   Read More »
May 28, 2014
Plans to re-introduce U.S. injectable generics products  Read More »
May 23, 2014
To combine ClinPay with clinical technology platform   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On